University of Nebraska/Creighton University Joint Division of Pediatric Cardiology, Children's Hospital and Medical Center, Omaha, Nebraska, USA.
Catheter Cardiovasc Interv. 2011 Jul 1;78(1):93-100. doi: 10.1002/ccd.22964. Epub 2011 Mar 31.
We describe a hybrid approach to the treatment of aortic obstruction after stage 1 palliation (S1P) of hypoplastic left heart syndrome.
Recurrent aortic obstruction is a common problem after S1P of hypoplastic left heart syndrome. Even mild aortic obstruction is poorly tolerated so early and definitive therapy is desirable. Although stent implantation is an effective treatment for aortic obstruction in older children and adults, technical issues due to small vessels and concerns regarding future potential for expansion have generally precluded the use of stents in this setting.
Six patients underwent hybrid aortic reconstruction (HAR) in the operating room or catheterization laboratory, with the interventional cardiologist and cardiac surgeon working in cooperation.
Patients had a mean weight of 5.8 kg (2.9-7.7) and a mean age of 5.6 months (0.5-12.9) at the time of HAR. Five patients had undergone prior balloon angioplasty at a mean age of 2.8 months (2.1-3.5), and five had moderately depressed single ventricular function prior to HAR. The balloons used had a diameter of 7-10 mm and introducer sheath size ranged from 6 to 10 F. There were no immediate or late procedure related complications. Stent redilation was performed in 5 patients for relief of recurrent obstruction or to keep pace with somatic growth. At a median follow up of 4.8 years (0.2-7.9), there were 3 patients progressing well after Fontan palliation and 3 deaths.
HAR allows for placement of stents that can ultimately reach adult size in small infants who have recurrent aortic obstruction after balloon angioplasty following S1P. Advantages include freedom from delivery sheath constraints when determining stent type/size, facilitation of precise stent position, and avoidance of vascular damage or hemodynamic compromise during the procedure. Longer follow-up and larger experience are required to determine if this therapy will provide a long-term solution to this difficult problem.
我们描述了一种治疗左心发育不全综合征一期姑息治疗(S1P)后主动脉瓣狭窄的混合治疗方法。
左心发育不全综合征 S1P 后,主动脉瓣再狭窄是一种常见问题。即使轻度主动脉瓣狭窄也很难在早期耐受,因此需要明确的治疗。尽管支架植入术是治疗大龄儿童和成人主动脉瓣狭窄的有效方法,但由于血管较小而导致的技术问题以及对未来扩张潜力的担忧,通常不建议在这种情况下使用支架。
六名患者在手术室或导管室进行了混合式主动脉重建(HAR),介入心脏病专家和心脏外科医生合作进行。
患者 HAR 时的平均体重为 5.8kg(2.9-7.7),平均年龄为 5.6 个月(0.5-12.9)。五名患者在 HAR 前平均年龄为 2.8 个月(2.1-3.5)时曾接受过球囊血管成形术,五名患者在 HAR 前有中度单心室功能不全。使用的球囊直径为 7-10mm,引入鞘管尺寸范围为 6 至 10F。无即刻或晚期手术相关并发症。5 名患者因反复梗阻或与躯体生长同步进行了支架再扩张。在中位随访 4.8 年(0.2-7.9)后,Fontan 姑息治疗后有 3 名患者进展良好,3 名患者死亡。
HAR 允许在 S1P 后球囊血管成形术后发生再狭窄的小婴儿中放置最终可达到成人大小的支架。其优点包括在确定支架类型/尺寸时不受输送鞘管限制,有利于精确放置支架,以及在手术过程中避免血管损伤或血流动力学受损。需要更长的随访和更多的经验来确定这种治疗方法是否能为这个难题提供长期解决方案。